You have 9 free searches left this month | for more free features.


Showing 1 - 25 of 1,704


Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)

Not yet recruiting
  • Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram
  • disulfiram and cisplatin
  • cisplatin
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 26, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Strasbourg (Split Cisplatin, Cisplatin, Radiotherapy)

  • Squamous Cell Carcinoma of the Head and Neck
  • Split Cisplatin
  • +2 more
  • Strasbourg, France
    Centre Paul Strauss
Mar 10, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)

  • Hepatocellular Carcinoma
  • Cisplatin
  • Hong Kong, Hong Kong
    Department of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cisplatin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 9, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)

  • Carcinoma, Squamous Cell
  • Head and Neck Cancer
  • Cisplatin
  • XRT
  • Lexington, Kentucky
    University of Kentucky
Nov 17, 2021

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Head and Neck Squamous Cell Carcinoma Trial in Tours (Docetaxel, Cisplatin, Fluorouracil)

  • Head and Neck Squamous Cell Carcinoma
  • Tours, France
    Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan
Mar 10, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)

  • Triple-negative Metastatic Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 29, 2021

Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

  • Untreated Resectable Pancreatic Adenocarcinoma
  • +2 more
  • Paclitaxel protein bound
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
May 10, 2022

Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)

Active, not recruiting
  • Biliary Tract Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 26, 2021

Esophageal Squamous Cell Carcinoma Trial in Beijing (nab-paclitaxel, Cisplatin, Capecitabine)

  • Esophageal Squamous Cell Carcinoma
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 13, 2022

Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)

  • Urothelial Carcinoma of the Urinary Bladder
  • New York, New York
    Columbia University Medical Center- HIP
Feb 3, 2022

Advanced Solid Tumors Trial (ABBV-706, Cisplatin, Budigalimab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 28, 2022

Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • San Antonio, Texas
    Mays Cancer Center
Mar 11, 2022

Carcinoma, Small Cell Trial in Hwasun (Belotecan, Etoposide, Cisplatin)

  • Carcinoma, Small Cell
  • Hwasun, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 2, 2021

Muscle-Invasive Bladder Carcinoma Trial in Roma (Nivolumab, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Roma, Italy
    Roberto iacovelli
Jan 10, 2022